Beta-blockers

DRUG3 trials

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Boehringer Ingelheim, Weill Medical College of Cornell University

Conditions

Acute ST-Elevation Myocardial InfarctionHFpEFHFpEF - Heart Failure With Preserved Ejection FractionHeart FailureNeoplasm

Phase 4

Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)

Enrolling by invitationNCT07298993

Weill Medical College of Cornell UniversityHeart Failure, HFpEF, HFpEF - Heart Failure With Preserved Ejection Fraction

Start: 2026-02-02End: 2029-04-01Target: 240Updated: 2026-02-27

Unknown Phase

The Use of Angiotensin Receptor Blockers and the Risk of Cancer

CompletedNCT02215733

Boehringer IngelheimNeoplasm

Start: 2011-02-28Updated: 2014-08-13

A Clinical Study on the Interventional Clinical Efficacy of Shexiang Baoxin Pills in Patients with STEMI (Qi-Stagnation and Blood-Stasis Syndrome) After PCI.

Active, not recruitingChiCTR2500101820

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese MedicineAcute ST-Elevation Myocardial Infarction

Start: 2025-05-01Updated: 2025-05-05